Elevating VEGF-A and PDGF-BB Secretion by Salidroside Enhances Neoangiogenesis in Diabetic Hind-limb Ischemia

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Dec 13

PMID 29228603

Citations 13

Authors

Agnes Dwi Ariyanti

Julita Sisjayawan

Jing Zhang

Jian-Qi Zhang

Gui-Xue Wang

Makoto Miyagishi

Shou-Rong Wu

Vivi Kasim

Affiliations

Soon will be listed here.

Abstract

Hind-limb ischemia (HLI) is one of the major complication of diabetic patients. Angiogenesis potential in diabetic patients is severely disrupted, and the mechanism underlying it has not been fully elucidated, making it an obstacle for developing an efficient therapeutic angiogenesis strategy. Skeletal muscle cells, through their paracrine function, had been known to be critical for neoangiogenesis. Here we found that hyperglycemia upregulates the expression of skeletal muscle cells prolyl hydroxylase domain 3 (PHD3), which resulted in the decrease of the secretion of angiogenic factors, especially VEGF-A and PDGF-BB. We showed that treatment with salidroside, a small molecule drug, significantly suppresses PHD3 expression and increases VEGF-A and PDGF-BB secretion from skeletal muscle cells, which in turn enhances the proliferation and migration potentials of endothelial and smooth muscle cells. Finally, we demonstrated that intramuscular injection of salidroside into the ischemic hind limbs of diabetic HLI model mice could efficiently induce neoangiogenesis and blood perfusion recovery. Thus, our novel findings not only reveal the effects of hyperglycemia on the angiogenesis potential of skeletal muscle cells and the mechanism underlying it, but also provides a novel finding suggesting that salidroside might be a potential small molecule drug for diabetic HLI.

Citing Articles

A review of platelet-rich plasma for enteric fistula management.

Liang S, Zheng Z, Li Y, Yang Y, Qin L, Zhao Z Front Bioeng Biotechnol. 2023; 11:1287890.

PMID: 38033816 PMC: 10685294. DOI: 10.3389/fbioe.2023.1287890.

The Concentration of Pro- and Antiangiogenic Factors in Saliva and Gingival Crevicular Fluid Compared to Plasma in Patients with Peripheral Artery Disease and Type 2 Diabetes.

Gregorczyk-Maga I, Szustkiewicz-Karon A, Gajda M, Kapusta M, Maga W, Schonborn M Biomedicines. 2023; 11(6).

PMID: 37371691 PMC: 10296086. DOI: 10.3390/biomedicines11061596.

SGLT2 inhibitor empagliflozin promotes revascularization in diabetic mouse hindlimb ischemia by inhibiting ferroptosis.

Han J, Luo L, Wang Y, Miyagishi M, Kasim V, Wu S Acta Pharmacol Sin. 2022; 44(6):1161-1174.

PMID: 36509902 PMC: 10203292. DOI: 10.1038/s41401-022-01031-0.

Therapeutic potential and molecular mechanisms of salidroside in ischemic diseases.

Han J, Luo L, Wang Y, Wu S, Kasim V Front Pharmacol. 2022; 13:974775.

PMID: 36060000 PMC: 9437267. DOI: 10.3389/fphar.2022.974775.

Single-Cell Transcriptomics of Proliferative Phase Endometrium: Systems Analysis of Cell-Cell Communication Network Using CellChat.

Fang Z, Tian Y, Sui C, Guo Y, Hu X, Lai Y Front Cell Dev Biol. 2022; 10:919731.

PMID: 35938159 PMC: 9352955. DOI: 10.3389/fcell.2022.919731.

References

Taniguchi C, Finger E, Krieg A, Wu C, Diep A, LaGory E . Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes. Nat Med. 2013; 19(10):1325-30. PMC: 4089950. DOI: 10.1038/nm.3294. View

Stabile E, Burnett M, Watkins C, Kinnaird T, Bachis A, la Sala A . Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation. 2003; 108(2):205-10. DOI: 10.1161/01.CIR.0000079225.50817.71. View

Zhang J, Kasim V, Xie Y, Huang C, Sisjayawan J, Ariyanti A . Inhibition of PHD3 by salidroside promotes neovascularization through cell-cell communications mediated by muscle-secreted angiogenic factors. Sci Rep. 2017; 7:43935. PMC: 5339704. DOI: 10.1038/srep43935. View

Murray J, Balan C, Allgeier A, Kasparian A, Viswanadhan V, Wilde C . Dipeptidyl-quinolone derivatives inhibit hypoxia inducible factor-1α prolyl hydroxylases-1, -2, and -3 with altered selectivity. J Comb Chem. 2010; 12(5):676-86. DOI: 10.1021/cc100073a. View

Zheng T, Yang X, Wu D, Xing S, Bian F, Li W . Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway. Br J Pharmacol. 2015; 172(13):3284-301. PMC: 4500366. DOI: 10.1111/bph.13120. View

Ishikura K, Misu H, Kumazaki M, Takayama H, Matsuzawa-Nagata N, Tajima N . Selenoprotein P as a diabetes-associated hepatokine that impairs angiogenesis by inducing VEGF resistance in vascular endothelial cells. Diabetologia. 2014; 57(9):1968-76. DOI: 10.1007/s00125-014-3306-9. View

Marxsen J, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T . Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J. 2004; 381(Pt 3):761-7. PMC: 1133886. DOI: 10.1042/BJ20040620. View

Yoshinaga M, Nakatsuka Y, Vandenbon A, Ori D, Uehata T, Tsujimura T . Regnase-1 Maintains Iron Homeostasis via the Degradation of Transferrin Receptor 1 and Prolyl-Hydroxylase-Domain-Containing Protein 3 mRNAs. Cell Rep. 2017; 19(8):1614-1630. DOI: 10.1016/j.celrep.2017.05.009. View

Lai J, Chen F, Chen J, Ruan G, He M, Chen C . Overexpression of decorin promoted angiogenesis in diabetic cardiomyopathy via IGF1R-AKT-VEGF signaling. Sci Rep. 2017; 7:44473. PMC: 5349602. DOI: 10.1038/srep44473. View

10.

Linger R, Belikoff E, Yan Y, Li F, Wantuch H, Fitzsimons H . Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor. BMC Biotechnol. 2016; 16:30. PMC: 4804476. DOI: 10.1186/s12896-016-0263-z. View

11.

Rishi M, Selvaraju V, Thirunavukkarasu M, Shaikh I, Takeda K, Fong G . Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia. Microvasc Res. 2014; 97:181-8. DOI: 10.1016/j.mvr.2014.10.009. View

12.

Bruick R, McKnight S . A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001; 294(5545):1337-40. DOI: 10.1126/science.1066373. View

13.

Zhang J, Liu A, Hou R, Zhang J, Jia X, Jiang W . Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1alpha-activated and VEGF-mediated pathway. Eur J Pharmacol. 2009; 607(1-3):6-14. DOI: 10.1016/j.ejphar.2009.01.046. View

14.

Faglia E, Clerici G, Clerissi J, Gabrielli L, Losa S, Mantero M . Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study. Diabetes Care. 2009; 32(5):822-7. PMC: 2671089. DOI: 10.2337/dc08-1223. View

15.

Annex B . Therapeutic angiogenesis for critical limb ischaemia. Nat Rev Cardiol. 2013; 10(7):387-96. DOI: 10.1038/nrcardio.2013.70. View

16.

Caporali A, Meloni M, Nailor A, Mitic T, Shantikumar S, Riu F . p75(NTR)-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia. Nat Commun. 2015; 6:8024. PMC: 4538859. DOI: 10.1038/ncomms9024. View

17.

Futrega K, King M, Lott W, Doran M . Treating the whole not the hole: necessary coupling of technologies for diabetic foot ulcer treatment. Trends Mol Med. 2014; 20(3):137-42. DOI: 10.1016/j.molmed.2013.12.004. View

18.

Wu S, Nishiyama N, Kano M, Morishita Y, Miyazono K, Itaka K . Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene. Mol Ther. 2008; 16(7):1227-34. DOI: 10.1038/mt.2008.90. View

19.

Yu Y, Yang P, Chuah Q, Huang Y, Peng C, Lee Y . Radiation-induced senescence in securin-deficient cancer cells promotes cell invasion involving the IL-6/STAT3 and PDGF-BB/PDGFR pathways. Sci Rep. 2013; 3:1675. PMC: 3628221. DOI: 10.1038/srep01675. View

20.

Ramachandran A, Ma R, Snehalatha C . Diabetes in Asia. Lancet. 2009; 375(9712):408-18. DOI: 10.1016/S0140-6736(09)60937-5. View